Vanguard Group
PGEN icon

Vanguard Group’s Precigen PGEN Stock Holding History

Vanguard Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$43.8M Buy
10,479,452
+1,537,167
+17% +$5.95M ﹤0.01% 2232
2025
Q3 		$29.4M Sell
8,942,285
-127,744
-1% -$361K ﹤0.01% 2433
2025
Q2 		$12.9M Buy
9,070,029
+274,070
+3% +$389K ﹤0.01% 2767
2025
Q1 		$13.1M Buy
8,795,959
+465,468
+6% +$733K ﹤0.01% 2698
2024
Q4 		$9.33M Buy
8,330,491
+2,350
+0% +$2K ﹤0.01% 2998
2024
Q3 		$7.89M Buy
8,328,141
+1,568,781
+23% +$1.98M ﹤0.01% 3071
2024
Q2 		$10.7M Sell
6,759,360
-8,874
-0.1% -$12.9K ﹤0.01% 2877
2024
Q1 		$9.81M Buy
6,768,234
+19,875
+0.3% +$28.5K ﹤0.01% 2971
2023
Q4 		$9.04M Sell
6,748,359
-202,515
-3% -$238K ﹤0.01% 3005
2023
Q3 		$9.87M Buy
6,950,874
+130,030
+2% +$184K ﹤0.01% 2888
2023
Q2 		$7.84M Buy
6,820,844
+126,864
+2% +$150K ﹤0.01% 3082
2023
Q1 		$7.1M Buy
6,693,980
+1,811,840
+37% +$2.61M ﹤0.01% 3140
2022
Q4 		$7.42M Sell
4,882,140
-205,327
-4% -$353K ﹤0.01% 3096
2022
Q3 		$10.8M Sell
5,087,467
-13,035
-0.3% -$27.5K ﹤0.01% 2926
2022
Q2 		$6.83M Sell
5,100,502
-2,694,905
-35% -$4M ﹤0.01% 3201
2022
Q1 		$16.4M Sell
7,795,407
-2,270,908
-23% -$5.53M ﹤0.01% 2883
2021
Q4 		$37.3M Buy
10,066,315
+875,306
+10% +$3.77M ﹤0.01% 2514
2021
Q3 		$45.9M Buy
9,191,009
+30,708
+0.3% +$177K ﹤0.01% 2413
2021
Q2 		$59.7M Buy
9,160,301
+421,678
+5% +$2.95M ﹤0.01% 2269
2021
Q1 		$60.2M Buy
8,738,623
+1,634,752
+23% +$13.8M ﹤0.01% 2213
2020
Q4 		$72.5M Buy
7,103,871
+310,288
+5% +$2.01M ﹤0.01% 2005
2020
Q3 		$23.8M Sell
6,793,583
-805,648
-11% -$3.82M ﹤0.01% 2375
2020
Q2 		$37.9M Sell
7,599,231
-320,659
-4% -$1.09M ﹤0.01% 2141
2020
Q1 		$26.9M Buy
7,919,890
+228,901
+3% +$988K ﹤0.01% 2156
2019
Q4 		$42.1M Buy
7,690,989
+567,494
+8% +$3.19M ﹤0.01% 2197
2019
Q3 		$40.7M Buy
7,123,495
+451,360
+7% +$3.07M ﹤0.01% 2171
2019
Q2 		$51.1M Buy
6,672,135
+1,686,028
+34% +$9.08M ﹤0.01% 2089
2019
Q1 		$26.2M Sell
4,986,107
-1,284,043
-20% -$8.9M ﹤0.01% 2383
2018
Q4 		$41M Buy
6,270,150
+65,286
+1% +$732K ﹤0.01% 2126
2018
Q3 		$107M Buy
6,204,864
+81,918
+1% +$1.22M ﹤0.01% 1768
2018
Q2 		$85.4M Buy
6,122,946
+462,482
+8% +$7.81M ﹤0.01% 1857
2018
Q1 		$86.8M Buy
5,660,464
+541,035
+11% +$7.74M ﹤0.01% 1789
2017
Q4 		$59M Buy
5,119,429
+318,776
+7% +$4.75M ﹤0.01% 1980
2017
Q3 		$91.3M Buy
4,800,653
+366,774
+8% +$7.55M ﹤0.01% 1762
2017
Q2 		$107M Buy
4,433,879
+147,517
+3% +$3.23M 0.01% 1633
2017
Q1 		$85M Buy
4,286,362
+189,548
+5% +$4.23M ﹤0.01% 1746
2016
Q4 		$98.7M Buy
4,096,814
+117,664
+3% +$3.28M 0.01% 1625
2016
Q3 		$111M Buy
3,979,150
+177,130
+5% +$4.68M 0.01% 1488
2016
Q2 		$92.7M Buy
3,802,020
+101,993
+3% +$2.89M 0.01% 1569
2016
Q1 		$124M Buy
3,700,027
+172,722
+5% +$5.44M 0.01% 1328
2015
Q4 		$105M Buy
3,527,305
+128,751
+4% +$4.34M 0.01% 1432
2015
Q3 		$107M Buy
3,398,554
+575,569
+20% +$28.1M 0.01% 1378
2015
Q2 		$137M Buy
2,822,985
+82,747
+3% +$3.49M 0.01% 1323
2015
Q1 		$119M Buy
2,740,238
+489,997
+22% +$17.6M 0.01% 1377
2014
Q4 		$59.2M Buy
2,250,241
+116,393
+5% +$2.55M ﹤0.01% 1746
2014
Q3 		$37.9M Buy
2,133,848
+224,511
+12% +$4.58M ﹤0.01% 1941
2014
Q2 		$45.9M Buy
1,909,337
+110,596
+6% +$2.24M ﹤0.01% 1885
2014
Q1 		$45.2M Buy
1,798,741
+1,738,359
+2,879% +$48.1M ﹤0.01% 1862
2013
Q4 		$1.37M Buy
60,382
+41,201
+215% +$833K ﹤0.01% 3325
2013
Q3 		$434K Buy
+19,181
New +$443K ﹤0.01% 3575

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Vanguard Group's PGEN Position: Q4 2025 in Review

Vanguard Group increased its Precigen (PGEN) stake by 17% in Q4 2025, buying an estimated $5.95M and bringing the position to 10,479,452 shares worth $43.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Vanguard Group first reported a position in PGEN in Q3 2013 and has held it in 50 quarters since. The position peaked at $137M in Q2 2015. 179 funds tracked by Wall St. Rank hold PGEN as of Q4 2025.

  • Vanguard Group held 10,479,452 shares of Precigen worth $43.8M as of Q4 2025.
  • Vanguard Group bought 1,537,167 Precigen shares in Q4 2025, an estimated $5.95M.
  • Precigen made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2232 holding.
  • Vanguard Group first reported a position in Precigen in Q3 2013 and has held it in 50 quarters since.
  • Vanguard Group's Precigen position peaked at $137M in Q2 2015.
  • 179 funds tracked by Wall St. Rank held Precigen as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.